Affimed (0HL9.L) Stock Price
$0 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Affimed, AI stock picks, stock alerts and much more.
0HL9.L AI Stock Analysis
AI stock analysis for 0HL9.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Affimed (0HL9.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Affimed (0HL9.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Affimed (0HL9.L), currently trading at $0, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0HL9.L
-
Affimed N.
-
Symbol
0HL9.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
1523
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.1 1.2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
News
0HL9.L Alternative Data
Web Traffic
Affimed receives an estimated 5939 monthly visitors to affimed.com.
-
Web Traffic
5939
-
Change from Previous Month
28.8%
-
3 Month Change
27.9%
-
YoY Change
27.9%
Twitter Followers
Affimed has 764 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
764
-
Daily Change
0.1%
-
1 Month Change
0.5%
-
3 Month Change
0.7%
LinkedIn Followers
7,061 are following Affimed on LinkedIn, up by 0.7% over the last month.
-
LinkedIn Followers
7061
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
1.9%
LinkedIn Employees
According to LinkedIn, Affimed has 74 employees, down by -5.1% over the last month.
-
LinkedIn Employees
74
-
Daily Change
5.1%
-
1 Month Change
5.1%
-
3 Month Change
14%
News Mentions
Affimed was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Affimed has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
0HL9.L Financials
0HL9.L Key Metrics
-
Total Revenue
€155K
-
Net Income
-€15.1M
-
Earnings per Share
€0
-
Free cash flow
-€11.1M
-
EBITDA
-€14.4M
-
EBITDA Ratio
-93.2
-
Total Assets
€40M
0HL9.L 2-year Revenue & Income
0HL9.L 2-year Free Cash Flow
0HL9.L Technicals
0HL9.L SMA
0HL9.L RSI
FAQ
What's the current price of Affimed (0HL9.L) Stock?
The price of an Affimed (0HL9.L) share is $0.
What's the market cap of Affimed?
The current market cap of Affimed is 1523.
Should I buy or sell 0HL9.L?
Affimed exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Affimed a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Affimed stock. There are several bearish signals and market challenges that could negatively impact Affimed's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Affimed (0HL9.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Affimed stock right now, as the outlook appears bearish.
What are some stocks similar to Affimed (0HL9.L) that investors often compare it to?
Affimed (0HL9.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Affimed's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Affimed's stock price to be around $0 in 2026. Starting from the current price of $0, this represents a 0% change in price, indicating a neutral outlook for the stock.
How to buy Affimed (0HL9.L) Stock?
Affimed stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Affimed shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.